In fact, some conventional DNA hypomethylating drugs, including 5-azacytidine and decitabine, can upregulate the expression of γH2AX and p21 and arrest the cell cycle of colon cancer cells in a p53-dependent fashion. Here, TP53 is linked to colonic neoplasm.